___

[1] Tacconelli, E.; Carrara, E.; Savoldi, A.; Harbarth, S.; Mendelson, M.; Monnet, D.L.; Pulcini, C.; Kahlmeter, G.; Kluytmans, J.; Carmeli, Y., “Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis”, Lancet Infect. Dis. 18, 318–327, 2018.

[2] Antunes LCS, Visca P, Towner KJ., “Acinetobacter baumannii: evolution of a global pathogen”, Pathog Dis, 71:292–301, 2014.

[3] Darvishi, M., “Virulence factor Profile and Antimicrobial Resistance of Acinetobacter baumannii Strain isolated from various References 114 infection Recovered from immunosuppressive patients", Biomedical Pharmacology Journal, 9, 1057-1062, 2016.

[4] Kim, M.H.; Jeong, H.; Sim, Y.M.; Lee, S.; Yong, D.; Ryu, C.M.; Choi, J.Y., “Using Comparative Genomics to Understand Molecular Features of Carbapenem-Resistant Acinetobacter baumannii from South Korea Causing Invasive Infections and Their Clinical Implications”, PLoS ONE, 15, 2020. https://doi.org/10.1371/journal.pone.0229416

[5] Barbe, V., Vallenet, D., Fonknechten, N., Kreimeyer, A., Oztas, S., Labarre, L., & Ornston, L. N., “Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium”, Nucleic acids research, 32, 5766-5779, 2004.

[6] Hamidian M, Nigro SJ., “Emergence, molecular mechanisms and global spread of carbapenemresistant Acinetobacter baumannii”, Microb Genom 5(10):e000306, 2019.

[7] Ahmad, N. H., & Mohammad, G. A., “Identification of Acinetobacter baumannii and Determination of MDR and XDR Strains”, Baghdad Science Journal, 17(3), 726-732, 2020.

[8] Li, P., Li, H., Lei, H., Liu, W., Zhao, X., Guo, L., & Bai, C. “Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A. baumannii in two comprehensive hospitals of Beijing, China”, Frontiers in microbiology, 6, 950 -997, 2015.

[9] Ali, H. M., Salem, M. Z., El-Shikh, M. S., Megeed, A. A., Alogaibi, Y. A., & Talea, I. A. “Investigation of the virulence factors and molecular characterization of the clonal relations of multidrug-resistant Acinetobacter baumannii isolates”, Journal of AOAC International, 100, 152-158, 2017.

[10] Kareem, S. M., Al-Kadmy, I. M., Al-Kaabi, M. H., Aziz, S. N., & Ahmad, M., “Acinetobacter baumannii virulence is enhanced by the combined presence of virulence factors genes phospholipase C (plcN) and elastase (lasB)”, Microbial pathogenesis, 110, 568-572, 2017.

[11] Mohajeri, P., Sharbati, S., Farahani, A., & Rezaei, Z., “Evaluate the frequency distribution of non-adhesive virulence factors in carbapenemase-producing Acinetobacter baumannii isolated from clinical samples in Kermanshah”, Journal of natural science, biology, and medicine, 7, 58- 64, 2016.

[12] Braun, G., & Vidotto, M. C., “Evaluation of adherence, hemagglutination, and presence of genes codifying for virulence factors of Acinetobacter baumannii causing urinary tract infection”, Memórias do Instituto Oswaldo Cruz, 99, 839-844, 2004.

[13] Johnson JR, Stell AL, “Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogenic and host compromise”, Journal of Infected Disease. 181, 261-272, 2000.

[14] Zong, Z., Lü, X., Valenzuela, J. K., Partridge, S. R., & Iredell, J., “An outbreak of carbapenemresistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China”, International Journal of antimicrobial agents, 31, 50-54, 2008.

[15] McConnell, M. J., Pérez-Ordóñez, A., Pérez-Romero, P., Valencia, R., Lepe, J. A., VázquezBarba, I., & Pachón, J., “Quantitative real-time PCR for the detection of Acinetobacter baumannii colonization in the hospital environment”, Journal of clinical microbiology, 50, 1412-1414, 2012.

[16] Bandana, K., Jashandeep, K. and Jagdeep, K., ‘Phospholipases in Bacterial Virulence and Pathogenesis”, Advances in Biotechnology & Microbiology, 10, 106-113, 2018.

[17] Antunes, L., Visca, P., & Towner, K. J., “Acinetobacter baumannii: evolution of a global pathogen", Pathogens and Disease, 71, 292-301, 2014.

[18] Stahl, J., Bergmann, H., Göttig, S., Ebersberger, I., & Averhoff, B., “Acinetobacter baumannii virulence is mediated by the concerted action of three phospholipases”, D. PloS one, 10(9): 0138360, 2015.

[19] Yu, H., He, X., Xie, W., Xiong, J., Sheng, H., Guo, S., Zhang, K., “Elastase LasB of Pseudomonas aeruginosa promotes biofilm formation partly through rhamnolipid-mediated regulation”, Canadian Journal of Microbiology, 60, 227-235, 2014. [20] Cathcart, G. R., Quinn, D., Greer, B., Harriott, P., Lynas, J. F., Gilmore, B. F., Walker, B., “Novel Inhibitors of the Pseudomonas aeruginosa Virulence Factor Pseudolysin/LasB: A Potential Therapeutic Approach for the Attenuation of Virulence Mechanisms in Pseudomonal Infection”, Antimicrobial agents and chemotherapy, 55, 2670–2678, 2011.

[21] AL-Kadmy, I. M., Ali, A. N. M., Salman, I. M. A., Khazaal, S. S., “Molecular characterization of Acinetobacter baumannii isolated from Iraqi hospital environment”, New microbes and new infections, 2, 51-57, 2018.

[22] Momtaz, H., Seifati, S. M., Tavakol, M., “Determining the prevalence and detection of the most prevalent virulence genes in Acinetobacter baumannii isolated from hospital infections”, International Journal of Medical Laboratory, 2, 87-97, 2015.

[23] He, X., Lu, F., Yuan, F., Jiang, D., Zhao, P., Zhu, J., Lu, G., “Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with over-expression of the AdeFGH efflux pump”, Antimicrobial agents and chemotherapy 59, 4817-4825, 2015.

[24] Ferreira, A., Fuentefria, D., Barth, A., Corção, G., “Molecular characterization of clinical multiresistant isolates of Acinetobacter sp. from hospitals in Porto Alegre, Brazil”, Revista da Sociedade Brasileira de Medicina Tropical, 44, 725-730, 2011.

[25] Ece, G., Erac, B., Cetin, H. Y., Ece, C., Baysak, A., “Antimicrobial susceptibility and clonal relation between Acinetobacter baumannii strains at a Tertiary Care Center in Turkey”, Jundishapur journal of microbiology, 8, 3-15, 2015.

[26] Ahmed, R. Z., Study the phenotype and genotype of some virulence factors of Acinetobacter baumannii isolated from different clinical samples, M.Sc. thesis. Baghdad University. Baghdad, Iraq, 2017.

[27] Li, P., Li, H., Lei, H., Liu, W., Zhao, X., Guo, L., Bai, C. “Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A. baumannii in two comprehensive hospitals of Beijing, China”, Frontiers in microbiology, 6, 950 -997, 2016.

[28] Medina-Presentado, J. C., Seija, V., Vignoli, R., Pontet, J., Robino, L., Cordeiro, N. F., Savio, E.,"Polyclonal endemicity of Acinetobacter baumannii in ventilated patients in an intensive care unit in Uruguay”, International Journal of Infectious Diseases, 17, 422-427, 2013.

[29] Aljindan, R., Alsamman, K., & Elhadi, N., “ERIC-PCR genotyping of Acinetobacter baumannii isolated from different clinical specimens”, Saudi Journal of Medicine and Medical Sciences, 6, 13, 2018.

[30] Maleki, A.; Vandyousefi, J.; Mirzaie, Z.; Ghafourian, S.; Kazemian H. Sadeghifard, N., "Molecular Analysis of the isolates of Acinetobacter baumannii isolated from Tehran Hospitals Using ERIC-PCR Method", Modern Medical of Laboratory, 1, 16-1 2016.

[31] Hammoudi, D., Moubareck, C. A., Hakime, N., Houmani, M., Barakat, A., Najjar, Z., & Sarkis, D. K., "Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon”, International Journal of Infectious Diseases, 36, 56-61, 2015.